Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Nature Biotechnology|February 2, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activityPeter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute, et al.
Clinical Immunology (Orlando, Fla.)|September 4, 2007
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous miceMamta Kalra, Ajay Grover, Neena Mehta, et al.
Cancer Discovery|February 10, 2021
A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell FunctionShannon Lange, Laurens G L Sand, Matthew Bell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cellsAnn Leen, Maheshika Ratnayake, Aaron Foster, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2010
Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human liversRashmi Singh, Jay Bullard, Mamta Kalra, et al.
Pediatric Hematology and Oncology|August 23, 2011
Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"Christian M Capitini, Stephen Gottschalk, Malcolm Brenner, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2017
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV ImmunotherapyRobert L Kruse, Thomas Shum, Xavier Legras, et al.
Cancer Research|February 26, 2017
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid TumorsKiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Pageof 22